Patents by Inventor Eric A. Schepis

Eric A. Schepis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11504534
    Abstract: The present disclosure is directed to a system and method for selectively and reversibly modulating targeted neural and non-neural tissue of a nervous system for the treatment of pain. An electrical stimulation is delivered to the treatment site that selectively and reversibly modulates the targeted neural- and non-neural tissue of the nervous structure, inhibiting the perception of pain while preserving other sensory and motor function, and proprioception.
    Type: Grant
    Filed: December 6, 2019
    Date of Patent: November 22, 2022
    Assignee: Avent, Inc.
    Inventors: Eric A. Schepis, David M. Page, Natalia Alexeeva, Lee C. Burnes
  • Patent number: 11471677
    Abstract: Articles and methods for non-invasively treating peripheral neuropathy via transcutaneous electrical stimulation of target nerve tissue are described. An exemplary article includes a support on which an electrode pair is positioned; a controller attached to the electrode pair via one or more leads; and a power supply connected to the controller. The article delivers electrical stimulation to the target nerve tissue via the electrode pair at a level sufficient to initiate vasodilation of vasculature within or adjacent the tissue. Meanwhile, the method includes positioning at least one electrode pair adjacent an area of skin overlying or in close proximity to the target nerve tissue and delivering electrical stimulation to the tissue via the electrode pair. The electrical stimulation is delivered at a level sufficient to initiate vasodilation of vasculature within or adjacent the tissue.
    Type: Grant
    Filed: December 8, 2017
    Date of Patent: October 18, 2022
    Assignee: Avent, Inc.
    Inventors: Jeremy D. Ollerenshaw, Leah M. Roldan, Elliot Blake Bourgeois, Eric A. Schepis
  • Patent number: 11464971
    Abstract: A system for selectively blocking nerve fiber activity in a target nerve is provided. The system includes one or more electrodes. The system further includes an electronic control system electrically attached to each electrode to deliver electrical stimulation to a target nerve to block nerve signal transmission of C-fibers in the target nerve such that the nerve signal transmission of A-fibers in the target nerve providing motor function and/or low-threshold sensory function is not blocked. A method of delivering electrical stimulation to selectively block nerve fiber activity in a target nerve and a kit for performing a procedure to selectively block nerve fiber activity are disclosed.
    Type: Grant
    Filed: August 24, 2015
    Date of Patent: October 11, 2022
    Assignee: Avent, Inc.
    Inventors: Eric A. Schepis, Phillip A. Schorr, Jeremy D. Ollerenshaw, Roger D. Massengale, Joshua D. White
  • Patent number: 11446498
    Abstract: The present disclosure is directed to a system and method for selectively and reversibly modulating targeted neural and non-neural tissue of a nervous system for the treatment of pain. An electrical stimulation is delivered to the treatment site that selectively and reversibly modulates the targeted neural- and non-neural tissue of the nervous structure, inhibiting pain while preserving other sensory and motor function, and proprioception.
    Type: Grant
    Filed: November 6, 2019
    Date of Patent: September 20, 2022
    Assignee: Avent, Inc.
    Inventors: Eric A. Schepis, David M. Page, Phillip A. Schorr, Shyamy R. Sastry, Leah Roldan, Natalia Alexeeva, Ryan Caldwell, Amol Soin
  • Patent number: 11432870
    Abstract: An electrosurgical device is provided that includes a probe extending in a longitudinal direction and having a proximal region and a distal region. An inner diameter of the probe defines a lumen. The probe has an electrically insulated portion extending from the proximal region to the distal region and an electrically exposed conductive portion located at the distal region. The electrically exposed conductive portion delivers radiofrequency energy to an area of tissue adjacent the distal region. The device also includes a heat transfer system for removing thermal energy from the area of tissue that is in thermal contact with the area of tissue. The heat transfer system removes from about 0.1 Watts to about 50 Watts of energy from the tissue. In addition, the heat transfer system can sufficiently draw heat away from the tissue without the use of a peristaltic pump for circulating a liquid inside the lumen.
    Type: Grant
    Filed: October 3, 2017
    Date of Patent: September 6, 2022
    Assignee: Avent, Inc.
    Inventors: Phillip A. Schorr, Eric A. Schepis, Skyler Canute, Joseph DiPietro, Sara Kebede, Tyler West Crone, Elliot Blake Bourgeois
  • Patent number: 11420054
    Abstract: The present disclosure is directed to a system and method modulating targeted neural and non-neural tissue of a nervous system for the treatment of head-and-face pain. Electrical stimulation is delivered transcutaneously to the treatment site that modulates the targeted neural- and non-neural tissue of the nervous structure, inhibiting nervous signaling and the perception of pain.
    Type: Grant
    Filed: February 20, 2020
    Date of Patent: August 23, 2022
    Assignee: Avent, Inc.
    Inventors: David M. Page, Eric A. Schepis, Jalpa Shah, Natalia Alexeeva
  • Publication number: 20220202471
    Abstract: The present invention is directed to a system and method for adaptive multivariate control for performing a radiofrequency (RF) ablation procedure with an energy delivery device. The system includes an energy source for delivering energy to a patient's body; one or more energy delivery devices; two or more sensors for measuring at least two factors related to an ablation procedure, respectively; and at least one processor.
    Type: Application
    Filed: December 30, 2020
    Publication date: June 30, 2022
    Inventors: Eric A. Schepis, Ryan B. Caldwell, Jalpa S. Shah, Lee C. Burnes, Amol Soin
  • Patent number: 11364050
    Abstract: A catheter placing instrument is provided. The catheter placing instrument includes an elongated body that extends in a longitudinal direction from a proximal end to a distal end. The elongated body has a top surface configured to receive a catheter extending from the proximal end to the distal end. The elongated body includes a catheter insertion section and a grip section. The catheter insertion section includes a catheter locking clamp located at the distal end of the elongated body, and the grip section includes a catheter guide. The catheter placing instrument can be used to place or implant any tubular medical device within a patient's body. A method of placing a tubular medical device at a deep location within a patient's body is also provided.
    Type: Grant
    Filed: February 27, 2019
    Date of Patent: June 21, 2022
    Assignee: Avent, Inc.
    Inventors: Steve S. Khalaj, Eric A. Schepis, Thomas D. Mina
  • Patent number: 11305115
    Abstract: The exemplified systems and methods facilitate a nerve conduction block at a target nerve using electrical stimulation applied from one or more electrodes located on a percutaneous lead that are placed in parallel, or substantially in parallel, and without direct contact, to a long axis of the peripheral nerve over an overlapping nerve region of greater than about 3 millimeters. The exemplified system and method can be further configured to block nerve condition without eliciting onset activity and co-excitation of non-targeted structures. The exemplified method and system can be performed using conventional percutaneous leads, though an improved percutaneous lead design is disclosed herein. In an aspect, an introducer is disclosed that facilitates accurate and consistent insertion of the percutaneous lead to the specified or intended position relative to the target nerve. In another aspect, a treatment kit comprising the various system components to treat pain is disclosed.
    Type: Grant
    Filed: March 15, 2019
    Date of Patent: April 19, 2022
    Assignee: Avent, Inc.
    Inventors: Ryan Caldwell, Eric A. Schepis, Phillip A. Schorr, Shyamant R. Sastry
  • Publication number: 20220105344
    Abstract: The present disclosure is directed to a system and method for selectively and reversibly modulating targeted neural and non-neural tissue of a nervous system for the treatment of pain. An electrical stimulation is delivered to the treatment site that selectively and reversibly modulates the targeted neural- and non-neural tissue of the nervous structure, inhibiting pain while preserving other sensory and motor function, and proprioception.
    Type: Application
    Filed: December 17, 2021
    Publication date: April 7, 2022
    Inventors: Eric A. Schepis, David M. Page, Phillip A. Schorr, Shyamy R. Sastry, Leah Roldan, Natalia Alexeeva, Ryan Caldwell, Amol Soin
  • Publication number: 20220096822
    Abstract: A method of providing therapy to a patient according to one embodiment includes generating an electrical noise signal by at least one noise generator controlled by a controller of a tunable noise system, partitioning the electrical noise signal into a plurality of discrete frequency bands, each of the discrete frequency bands having a corresponding bandwidth, delivering the electrical noise signal through one or more electrodes to the patient to target at least one of neural tissue or non-neural tissue of the patient, adjusting an amplitude of one or more of a voltage or current of the electrical noise signal within a selected frequency band of the plurality of discrete frequency bands to generate an adjusted electrical signal based on feedback received from the patient, and delivering the adjusted electrical signal through the one or more electrodes to provide therapy to the patient.
    Type: Application
    Filed: December 8, 2021
    Publication date: March 31, 2022
    Inventors: Eric A. Schepis, Amol Soin
  • Patent number: 11202909
    Abstract: The present disclosure is directed to a system and method for selectively and reversibly modulating targeted neural and non-neural tissue of a nervous system for the treatment of pain. An electrical stimulation is delivered to the treatment site that selectively and reversibly modulates the targeted neural- and non-neural tissue of the nervous structure, inhibiting pain while preserving other sensory and motor function, and proprioception.
    Type: Grant
    Filed: November 9, 2020
    Date of Patent: December 21, 2021
    Assignee: Avent, Inc.
    Inventors: Eric A. Schepis, David M. Page, Phillip A. Schorr, Shyamy R. Sastry, Leah Roldan, Natalia Alexeeva, Ryan Caldwell, Amol Soin
  • Publication number: 20210361934
    Abstract: A tubing assembly for use with an electronic catheter guidance systems is provided and includes a catheter and a stimulation electrode assembly, and an electrical connection for delivering a stimulation waveform to the stimulation electrode assembly. The catheter extends in a longitudinal direction and has a proximal end and a distal end that define a lumen therebetween. Further, the catheter is configured for placement within a patient's digestive tract. The stimulation electrode assembly is configured to deliver an electrical stimulation to tissue. A catheter guidance system and method for accurately placing a catheter in the digestive tract are also provided.
    Type: Application
    Filed: May 22, 2020
    Publication date: November 25, 2021
    Inventors: Karl Thomas Bjurbo, Eric A. Schepis, James F. Tassitano
  • Patent number: 10940312
    Abstract: The exemplified systems and methods facilitate a nerve conduction block at a target nerve using electrical stimulation applied from one or more electrodes located on a percutaneous lead that are placed in parallel, or substantially in parallel, and without direct contact, to a long axis of the peripheral nerve over an overlapping nerve region of greater than about 3 millimeters. The exemplified system and method can be further configured to block nerve condition without eliciting onset activity and co-excitation of non-targeted structures. The exemplified method and system can be performed using conventional percutaneous leads, though an improved percutaneous lead design is disclosed herein. In an aspect, an introducer is disclosed that facilitates accurate and consistent insertion of the percutaneous lead to the specified or intended position relative to the target nerve. In another aspect, a treatment kit comprising the various system components to treat pain is disclosed.
    Type: Grant
    Filed: March 15, 2019
    Date of Patent: March 9, 2021
    Assignee: Avent, Inc.
    Inventors: Eric A. Schepis, Phillip A. Schorr, Shyamy R. Sastry, Ryan Caldwell, Todd Hanson
  • Publication number: 20210052899
    Abstract: The present disclosure is directed to a system and method for selectively and reversibly modulating targeted neural and non-neural tissue of a nervous system for the treatment of pain. An electrical stimulation is delivered to the treatment site that selectively and reversibly modulates the targeted neural- and non-neural tissue of the nervous structure, inhibiting pain while preserving other sensory and motor function, and proprioception.
    Type: Application
    Filed: November 9, 2020
    Publication date: February 25, 2021
    Inventors: Eric A. Schepis, David M. Page, Phillip A. Schorr, Shyamy R. Sastry, Leah Roldan, Natalia Alexeeva, Ryan Caldwell, Amol Soin
  • Patent number: 10828491
    Abstract: The present disclosure is directed to a system and method for selectively and reversibly modulating targeted neural and non-neural tissue of a nervous system for the treatment of pain. An electrical stimulation is delivered to the treatment site that selectively and reversibly modulates the targeted neural- and non-neural tissue of the nervous structure, inhibiting pain while preserving other sensory and motor function, and proprioception.
    Type: Grant
    Filed: November 6, 2019
    Date of Patent: November 10, 2020
    Assignee: Avent, Inc.
    Inventors: Eric A. Schepis, David M. Page, Phillip A. Schorr, Shyamy R. Sastry, Leah Roldan, Natalia Alexeeva, Ryan Caldwell, Amol Soin
  • Patent number: 10792496
    Abstract: The exemplified systems and methods facilitate a nerve conduction block at a target nerve using electrical stimulation applied from one or more electrodes located on a percutaneous lead that are placed in parallel, or substantially in parallel, and without direct contact, to a long axis of the peripheral nerve over an overlapping nerve region of greater than about 3 millimeters. The exemplified system and method can be further configured to block nerve condition without eliciting onset activity and co-excitation of non-targeted structures. The exemplified method and system can be performed using conventional percutaneous leads, though an improved percutaneous lead design is disclosed herein. In an aspect, an introducer is disclosed that facilitates accurate and consistent insertion of the percutaneous lead to the specified or intended position relative to the target nerve. In another aspect, a treatment kit comprising the various system components to treat pain is disclosed.
    Type: Grant
    Filed: March 15, 2019
    Date of Patent: October 6, 2020
    Assignee: Avent, Inc.
    Inventors: Eric A. Schepis, Phillip A. Schorr, Shyamy R. Sastry, Ryan Caldwell, David M. Page, Amol Soin
  • Patent number: 10780270
    Abstract: The exemplified systems and methods facilitate a nerve conduction block at a target nerve using electrical stimulation applied from one or more electrodes located on a percutaneous lead that are placed in parallel, or substantially in parallel, and without direct contact, to a long axis of the peripheral nerve over an overlapping nerve region of greater than about 3 millimeters. The exemplified system and method can be further configured to block nerve condition without eliciting onset activity and co-excitation of non-targeted structures. The exemplified method and system can be performed using conventional percutaneous leads, though an improved percutaneous lead design is disclosed herein. In an aspect, an introducer is disclosed that facilitates accurate and consistent insertion of the percutaneous lead to the specified or intended position relative to the target nerve. In another aspect, a treatment kit comprising the various system components to treat pain is disclosed.
    Type: Grant
    Filed: March 15, 2019
    Date of Patent: September 22, 2020
    Assignee: Avent, Inc.
    Inventors: Eric A. Schepis, Phillip A. Schorr, Wanzhan Liu, Natalia Alexeeva, Shyamant R. Sastry, Amol Soin, David M. Page, Ryan Caldwell
  • Publication number: 20200269046
    Abstract: The present disclosure is directed to a system and method modulating targeted neural and non-neural tissue of a nervous system for the treatment of head-and-face pain. Electrical stimulation is delivered transcutaneously to the treatment site that modulates the targeted neural- and non-neural tissue of the nervous structure, inhibiting nervous signaling and the perception of pain.
    Type: Application
    Filed: February 20, 2020
    Publication date: August 27, 2020
    Inventors: David M. Page, Eric A. Schepis, Jalpa Shah, Natalia Alexeeva
  • Publication number: 20200269018
    Abstract: A multi-headed catheter for fluid delivery and a method of placing a multi-headed catheter for fluid delivery are provided. The multi-headed catheter includes a first tube extending along an axis, wherein the first tube has at least one exit hole provided at a distal end of the first tube to define a perfusion section of the first tube; and a second tube extending along the axis, wherein at least a portion of the second tube is disposed within the first tube, wherein the second tube has at least one exit hole provided at a distal end of the second tube to define a perfusion section of the second tube. The distal end of the second tube is configured to exit said first tube at an opening provided along a wall of the first tube. The perfusion sections of the first tube and the second tube can be independently placed to deliver fluid to distinct anatomical areas within a surgical wound site.
    Type: Application
    Filed: February 27, 2019
    Publication date: August 27, 2020
    Inventors: Steve S. Khalaj, Eric A. Schepis, Thomas D. Mina